THE ROLE OF ARTERIAL HYPERTENSION IN THE FORMATION OF CEREBRAL HEMODYNAMIC DISORDERS IN PATIENTS WITH THYROTOXICOSIS
DOI:
https://doi.org/10.32689/2786-7161-2026-2-1Ключові слова:
arterial hypertension, thyrotoxicosis, cerebral hemodynamic, ultrasound duplex scanАнотація
Background. This article examines the characteristics of cerebral haemodynamics in patients with thyrotoxicosis (TT), both with and without concomitant arterial hypertension (AH), and aims to determine the role of these factors in the development of haemodynamic disturbances. Materials and Methods. A total of 100 patients with TT, AH, and TT combined with AH, as well as 27 essentially healthy individuals, were examined. Using the transcranial duplex scanning method, we measured and analysed the linear blood flow velocity (LBFV) in intracranial vessels and the extracranial segments of the brachiocephalic vessels, the pulsatility index (PI), the resistance index (RI) and the total cerebral blood flow as the sum of the volumetric blood flow through both internal carotid arteries and the volumetric blood flow through both vertebral arteries. Results. In patients with TT, a statistically significant increase in LBFV, IR and IP were observed in the extra- and intracranial segments of the major arteries of the head and neck, which was more pronounced in patients with concomitant AH; this may indicate greater strain on haemodynamic compensatory mechanisms, marked dysregulation of vascular tone, and may complicate the course of the underlying disease in these patients. In the group of patients with TT and AH, a significant increase in total cerebral blood flow was also observed, suggesting that AH acts as an additional factor placing strain on the mechanisms compensating for cerebral blood flow, which may lead to their premature exhaustion. Conclusions. The results obtained suggest that AH should be regarded as an additional factor that significantly impairs cerebral haemodynamics, increases the risk of cerebrovascular complications and may lead to the rapid development of metabolic cerebral disorders in patients with TT.
Посилання
Avolio, A., Kim, M. O., Adji, A., Gangoda, S., Avadhanam, B., Tan, I., Butlin, M. (2018). Cerebral Haemodynamics: Effects of Systemic Arterial Pulsatile Function and Hypertension. Curr Hypertens Rep, 19 (20(3)), 20. http://doi.org/10.1007/s11906-018-0822-x
Brouwers, S., Sudano, I., Kokubo, Y., Sulaica, E. M. (2021). Arterial hypertension. Lancet, 17 (398(10296)), 249–261. http://doi.org/10.1016/S0140-6736(21)00221-X
Chaker, L., Cooper, D. S., Walsh, J. P., Peeters, R. P. (2024). Hyperthyroidism. Lancet, 24 (403(10428)), 768–780. http://doi.org/10.1016/S0140-6736(23)02016-0
Christie, I. N., Windsor, R., Mutsaerts, H. J. M. M., Tillin, T., Sudre, C. H., Hughes, A. D., Golay, X., Gourine, A. V., Hosford, P. S. (2022). Cerebral perfusion in untreated, controlled, and uncontrolled hypertension. J Cereb Blood Flow Metab, 42(12), 2188–2190. https://doi.org/10.1177/0271678X221124644
Debmalya, S., Saumitra, R., Singh, M. H. (2022). Interplay between cardiovascular and thyroid dysfunctions: A review of clinical implications and management strategies. Endocr Regul, 20 (56(4)), 311–328. http://doi.org/10.2478/enr-2022-0033
Fani, L., Roa Dueñas, O., Bos, D., Vernooij, M. W., Klaver, C. C. W., Ikram, M. K., Peeters, R. P., Ikram, M. A., Chaker, L. (2022). Thyroid status and brain circulation: The Rotterdam Study. J Clin Endocrinol Metab, 107(3), e1293–e1302. https://doi.org/10.1210/clinem/dgab744
Farrar, J., Frieden, T. (2025). WHO global report on hypertension 2025. Lancet, 15 (406(10517)), 2318–2319. http://doi.org/10.1016/S0140-6736(25)02208-1
Global report on hypertension 2025-High stakes: turning evidence into action. World Health Organization. Available at: https://www.who.int/publications/i/item/9789240115569
Göbel, A., Heldmann, M., Sartorius, A., Göttlich, M., Dirk, A.-L., Brabant, G., Münte, T. F. (2017). Mild thyrotoxicosis leads to brain perfusion changes: An arterial spin labelling study. J Neuroendocrinol, 29(1), e12446. https://doi.org/10.1111/jne.12446
Lee, S. Y., Pearce, E. N. (2023). Hyperthyroidism: A Review. JAMA, 17 (330(15)), 1472–1483. http://doi.org/10.1001/jama.2023.19052
Machado, M. F., Muela, H. C. S., Costa-Hong, V. A., Yassuda, M. S., Moraes, N. C., Memória, C. M., et al. (2020). Evaluation of cerebral autoregulation performance in patients with arterial hypertension on drug treatment. J Clin Hypertens (Greenwich), 22(11), 2114–2120. http://doi.org/10.1111/jch.14052
Monteiro, A., Castro, P., Pereira, G., Ferreira, C., Polonia, J., Lobo, M., Azevedo, E. (2024). Cerebral blood flow regulation and cognitive performance in hypertension. J Cereb Blood Flow Metab, 44(11), 1277–1287. https://doi.org/10.1177/0271678X241254680
Öksüz, S. B. T., Şahin, M. (2024). Thyroid and cardiovascular diseases. Turk J Med Sci, 1 (54(7)), 1420–1427. http://doi.org/10.55730/1300-0144.5927
Paschou, S. A., Bletsa, E., Stampouloglou, P. K., Tsigkou, V., Valatsou, A., Stefanaki, K., et al. (2022). Thyroid disorders and cardiovascular manifestations: an update. Endocrine, 75(3), 672–683. http://doi.org/10.1007/s12020-022-02982-4
Quiroz-Aldave, J. E., Durand-Vásquez, M. D. C., Lobato-Jeri, C. J., Muñoz-Moreno, J. M., Condori, D. C. D. G., Ildefonso-Najarro, S. P., et al. (2023). Thyrotoxic Cardiomyopathy: State of the Art. touchREV Endocrinol, 19(1), 78–84. http://doi.org/10.17925/EE.2023.19.1.78
Salas-Lucia, F. (2024). Mapping thyroid hormone action in the human brain. Thyroid, 34(7), 815–826. https://doi.org/10.1089/thy.2024.0120
Seiller, I., Pavilla, A., Ognard, J., Ozier-Lafontaine, N., Colombani, S., Ibarra, Y. C., Mejdoubi, M. (2021). Arterial hypertension and cerebral hemodynamics: impact of head-down tilt on cerebral blood flow (arterial spin-labeling-MRI) in healthy and hypertensive patients. J Hypertens, 1 (39(5)), 979–986. http://doi.org/10.1097/HJH.0000000000002709
Smith, P. J., Sherwood, A., Hinderliter, A. L., Mabe, S., Tyson, C., Avorgbedor, F., et al. (2022). Cerebrovascular Function, Vascular Risk, and Lifestyle Patterns in Resistant Hypertension. J Alzheimers Dis, 87(1), 345–357. http://doi.org/10.3233/JAD-215522
Soetedjo, N. N. M., Agustini, D., Permana, N. (2024). The impact of thyroid disorder on cardiovascular disease: Unraveling the connection and implications for patient care. Int J Cardiol Heart Vasc, 23:55:101536. http://doi.org/10.1016/j.ijcha.2024.101536
Suonsyrjä, N., Metso, S., Moilanen, E., Mustonen, J., Jaatinen, P., Pörsti, I. (2024). Haemodynamics of hyperthyroidism: Increased cardiac work and findings related to vasodilatation. Eur Thyroid J, 13(5), e240090. https://doi.org/10.1530/ETJ-24-0090
Ungvari, Z., Toth, P., Tarantini, S., Prodan, C. I., Sorond, F., Merkely, B., Csiszar, A. (2021). Hypertension-induced cognitive impairment: From pathophysiology to public health. Nat Rev Nephrol, 17, 639–654. https://doi.org/10.1038/s41581-021-00430-6
Webb, A. J. S., Werring, D. J. (2022). New Insights Into Cerebrovascular Pathophysiology and Hypertension. Stroke, 53(4), 1054–1064. http://doi.org/10.1161/STROKEAHA.121.035850
Wiersinga, W. M., Poppe, K. G., Effraimidis, G. (2023). Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol, 11(4), 282–298. http://doi.org/10.1016/S2213-8587(23)00005-0
Yang, L., Du, H., Zhang, X., Zhang, D, Su, X., Qiao, Z., Gao, B. (2024). Evaluation of the correlation between cerebral hemodynamics and blood pressure by comparative analysis of variation in cerebral blood flow in hypertensive versus normotensive individuals: A systematic review and meta-analysis. Biomol Biomed, 5 (24(4)), 775–786. http://doi.org/10.17305/bb.2024.10230
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
